News

Presentation Showcases Capabilities and Raises Profile for Constella in the UK

March 13—Constella took the opportunity to promote its pharmaceutical product development capabilities while educating biotech startups on strategic issues in clinical trials. Carolyn Belcher, Director of Programme Management, and Tigran Arzumanov, Business Development Executive, attended the Eastern Region Biotechnology Initiative (ERBI) networking event in Cambridge, UK, on Feb. 15, where Carolyn delivered a presentation on strategic issues of bringing a product through phase 2 testing.

The theme of the ERBI event was "What is the quickest and most economical way to get to the successful end of phase 2 clinical trials?" Carolyn’s presentation was dedicated to Fast Track methods in pre-clinical and clinical development and focused on a case study where the product was brought from bench to FTIM (First Time in Man) in eight months.

Carolyn and Tigran provided event attendees with information about Constella’s portfolio of services which can be used on an ad-hoc basis, specifically planning, regulatory consultancy, and clinical research.